| Original language | English (US) |
|---|---|
| Pages (from-to) | 1824-1826 |
| Number of pages | 3 |
| Journal | Multiple Sclerosis Journal |
| Volume | 27 |
| Issue number | 12 |
| DOIs | |
| State | Published - Oct 2021 |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Multiple Sclerosis Journal, Vol. 27, No. 12, 10.2021, p. 1824-1826.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The multiple sclerosis prodrome is just unspecific symptoms in radiologically isolated syndrome patients – No
AU - Tremlett, Helen
AU - Okuda, Darin T.
AU - Lebrun-Frenay, Christine
N1 - Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: H.T. is the Canada Research Chair for Neuroepidemiology and Multiple Sclerosis. Current research support received from the National Multiple Sclerosis Society, the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation. In addition, in the last 5 years, she has received research support from the UK MS Trust; travel expenses to present at CME conferences from the Consortium of MS Centres (2018), the National MS Society (2016 and 2018), ECTRIMS/ACTRIMS (2015, 2016, 2017, 2018, 2019 and 2020) and the American Academy of Neurology (2015, 2016 and 2019). Speaker honoraria are either declined or donated to an MS charity or to an unrestricted grant for use by H.T.’s research group. C.L.-F. has participated in expert boards for Novartis, Roche and Genzyme in the last 5 years. Speaker honoraria are either declined or donated to the URRIS research unit, University Cote d’Azur, Nice, France. She did not receive any financial compensation for her participation in the scientific committee of the French MS Society, ARSEP and ECTRIMS apart from travel expenses. D.T.O. received personal compensation for advisory and consulting services from Bristol Myers Squibb/Celgene, EMD Serono, Genzyme, Novartis, Osmotica, Viela Bio and research support from Biogen and EMD Serono.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85114880194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114880194&partnerID=8YFLogxK
U2 - 10.1177/13524585211035951
DO - 10.1177/13524585211035951
M3 - Article
C2 - 34494923
AN - SCOPUS:85114880194
SN - 1352-4585
VL - 27
SP - 1824
EP - 1826
JO - Multiple Sclerosis
JF - Multiple Sclerosis
IS - 12
ER -